Skip to main content
. Author manuscript; available in PMC: 2019 Feb 1.
Published in final edited form as: Int J Tuberc Lung Dis. 2018 Aug 1;22(8):937–944. doi: 10.5588/ijtld.17.0515

Figure 1.

Figure 1

Figure 1

Plasma trough concentrations of a) bedaquiline, b) delamanid, c) isoniazid and d) rifapentine after the administration of a single intramuscular injection on day 28 for various doses and release rates in adults. The red line represents the target trough concentration. The target concentration for bedaquiline is beyond the indicated scale, therefore not visible on the chart.